The Stanford Visiting Artist Fund, established in honor of Roberta Bowman Denning, brings internationally renowned artists to the university to engage with faculty and students in departments and programs across the campus.
The sustainability accelerator aims to co-create and scale solutions for climate and sustainability challenges globally. This request for proposals is for solutions for greenhouse gas removal from the atmosphere.
Stanford University’s Innovative Medicines Accelerator (IMA) is accepting proposals that address two major challenges in drug development: identifying drug candidates and optimization towards clinical leads.
SCI offers Innovation Awards to support collaborative projects focused on acceleration of basic, translational, clinical and population-based cancer research, and projects focused on cancer care, such as pancreatic, breast and gynecologic cancers.
The Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact is offering a Fall 2023 Seed Grant to support researchers and scientists in advancing specific domains of maternal-fetal science.
Stanford University’s Innovative Medicines Accelerator (IMA) is accepting proposals for projects that use a recent advance in human organ modeling to address the IMA’s goals of accelerating the prototyping of innovative medicines and vaccines.
DUE: October 2nd The Neuroscience:Translate program supports translational research addressing unmet needs in any area of neuroscience. Resulting technologies & therapies are intended to lead to licensing exits to eventually reach the patient.
SCI’s mission is to translate Stanford discoveries into individualized cancer care and prevention. In keeping with its goal of educating and empowering the next generation of cancer researchers, SCI offers funding to cancer research fellows.
To support biomedical research in diabetes, the Stanford Diabetes Research Center (SDRC) invites applications for the 2023-24 Pilot and Feasibility (P&F) Program led by Drs. Anna Gloyn and Sun H Kim.
